Private equity Carlyle acquires AkzoNobel’s Specialty Chemicals arm for €10.1bn

US-based private equity Carlyle has secured  AkzoNobel’s Specialty Chemicals division for €10.1bn (including debt), putting an end to a battle among various bidders, including Apollo Global Management, Hal Investments and the Bain Capital-Advent International consortium, which broke out over one year ago. Akzo Nobel’s division last year yielded revenues of €5bn and includes 5 business units which produce and market especially basic chemicals and employ 10,000 people, 2,500 of which in the Netherlands.